
Novo Nordisk A/S
Market Cap
$137.4B
Global Rank
#115
All-Time High
$315.6B
2023-12-31
Total Growth
+0%
since 2026
About Novo Nordisk A/S
Novo Nordisk A/S (NOVO-B.CO) is a Denmark-based company in the Drug Manufacturers - General industry, part of the Healthcare sector. With a current market capitalization of $137.4B, it is ranked #115 among the world's largest companies. Its market cap peaked at $315.6B and reached as high as rank #24 in 2023.
Novo Nordisk A/S Market Cap History (2026–2026)
Compare Novo Nordisk A/S
Ranking History
| Year | Market Cap | Rank | YoY Change |
|---|---|---|---|
| 2026 | $137.4B | #115(↓8) | -10.1% |
| 2025 | $152.9B | #107(↓78) | -46.4% |
| 2024 | $285.3B | #29(↓5) | -9.6% |
| 2023 | $315.6B | #24(↑11) | +50.7% |
| 2022 | $209.4B | #35(↑24) | +29.5% |
| 2021 | $161.6B | #59(↑30) | +75.6% |
| 2020 | $92.0B | #89(↓8) | +12.8% |
| 2019 | $81.6B | #81(↑2) | +32.9% |
| 2018 | $61.4B | #83(↓11) | -8.6% |
| 2017 | $67.2B | #72(↑20) | +35.4% |
| 2016 | $49.6B | #92(↓43) | -34.5% |
| 2015 | $75.8B | #49(↑27) | +55.9% |
| 2014 | $48.6B | #76(↑16) | +33.4% |
| 2013 | $36.5B | #92(↓18) | +10.5% |
| 2012 | $33.0B | #74(↑13) | +41.3% |
| 2011 | $23.3B | #87(↓40) | -46.7% |
| 2010 | $43.8B | #47(↑33) | +92.7% |
| 2009 | $22.7B | #80(↑65) | +150.6% |
| 2008 | $9.1B | #145(↓47) | -59.0% |
| 2007 | $22.1B | #98(↑102) | +189.1% |
| 2006 | $7.7B | #200(↑3) | +34.9% |
| 2005 | $5.7B | #203(↓67) | -39.8% |
| 2004 | $9.4B | #136(↓7) | +26.3% |
| 2003 | $7.5B | #129(↓8) | +19.5% |
| 2002 | $6.2B | #121(↓29) | -39.5% |
| 2001 | $10.3B | #92 |
Other Healthcare Companies
FAQ
What is Novo Nordisk A/S's market cap?
Novo Nordisk A/S (NOVO-B.CO) has a market capitalization of $137.4B, making it the #115 largest company in the world by market cap.
What was Novo Nordisk A/S's highest market cap?
Novo Nordisk A/S's all-time high market cap was $315.6B, reached in 2023-12-31. Its highest rank was #24 in 2023.
What sector is Novo Nordisk A/S in?
Novo Nordisk A/S is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in Denmark.
How has Novo Nordisk A/S's market cap changed over time?
Novo Nordisk A/S has been tracked since 2026. Its market cap has grown by 0% from $137.4B in 2026 to $137.4B today.









